Compendium klinische casussen:

PDF case report 5

Gilteritinib as salvage- and MRD-directed therapy in an early post-allo FLT3-ITD AML relapse

Accessible only to healthcare professionals authorized to prescribe

Clinical Case Study Compendium:

Video case report 1

Real-World Experiences by Dr. A. de Voeght; Sart Tilman-CHU Liège Video of the 1st case report

The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹

Video

Video of case report 5:

In this interview with Prof. Dr. M. Beckers (UZ Leuven, Belgium), she discusses her experiences with gilteritinib as salvage and MRD²-directed therapy in a post-transplant setting.

Intended for: practitioners hematology
Why: up-to-date knowledge TKI³ related target therapy
When: Watch now
Duration: 4 minutes

1: Acute Myeloid Leukemia; 2: Hematopoietic Stem Cell Transplantation

MAT-BE-XOS-2026-00005 MRT 2026

Log in and watch

AML: Acute Myeloid Leukemia

Dutch
English
French

Compendium klinische casussen:

PDF case report 5

Clinical Case Study Compendium:

Video case report 1

The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹

Video

You are now leaving aml-hematology.be.

Item was added to cart

Toestemming

Toestemming

Account aanmaken

Instemming

Toestemming

Toestemming

Verification code

Emailadres bevestigen en account aanmaken

Emailadres bevestigen en account aanmaken

Access with your RIZIV/INAMI or BIG Number

RIZIV/INAMI or BIG number *

Login

U gaat naar een externe website

U gaat naar een andere website van Astellas

Please confirm your involvement.